FAP and neoplasm: (166) have shown that combined treatment of mice bearing FAP-expressing xenografts with a [177lu]Lu-labelled FAP inhibitor ([177Lu]Lu-FAP-2287) and a PD-1 inhibitor increased recruitment of tumour-infiltrating CD8(+) T cells.